# Treatment of Refractory Schizophrenia With Riluzole

> **NCT00375050** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 34 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective

## Interventions

- **DRUG:** Riluzole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00375050
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2006-08-29
- **Final completion:** 2006-08-29
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2019-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00375050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00375050, "Treatment of Refractory Schizophrenia With Riluzole". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00375050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*